Massimo Radaelli

President & CEO at Noventia Pharma

Speaker

Chairman & CEO of Noventia Pharma. He founded Noventia Pharma, a dynamic privately owned European Specialty Pharma Company of about 80 people with its H.Q. in Lausanne and Subsidiaries in Italy Spain and Greece. Dr. Radaelli is also Executive Chairman and a shareholder of Pint Pharma Group, a company he founded in June 2012 to target Rare Diseases, Oncology and Hemoderivatives in Latin American and Emerging markets. Pint HQ Company is based in Switzerland with subsidiaries in Colombia, Mexico, Argentina, Ecuador, Peru, Chile, Venezuela and Central America Countries.
Dr. Radaelli is the President & CEO and Shareholder of Ferrer Italia, a J. V. company he founded in June 2016 to target Immune-in allergic diseases in Italy and Malta. Ferrer is engaged in the research, development, production and marketing of Vaccines in the Respiratory and Dermatology sector. Ferrer Acquired BioAllergologica in 2016 which has its Company HQ’s based in Rome Italy
From 1996 until 2009 he was President & CEO of Dompé International based in Lausanne, Switzerland, assuming also responsibility for all of Dompé Pharma Italian operations. He was also co-founder of the Dupont-Merck JV Italian Subsidiary where he was Marketing & Medical Director. Dr Radaelli held various Sales & Marketing and Strategic Marketing position from 1982 to 1991 during his tenure in Hoffman La Roche and Menarini.. He is a former member of the Board of Directors of Ariad Pharmaceuticals a leading US Biopharmaceutical Company focused on development and commercialization of biological therapeutics in severe Oncology diseases. He currently serves as a Board member of Arriani International a Specialty Pharma Greek Company and a Board member of Bioakos Pharma Labs a Specialty Pharma Italian Company with a Commercial Focus in Gynaecology-Dermatology and Pediatric Therarpeutic areas with its HQ in Florence Italy, as well as Lavipharm in Italy. Dr. Radaelli currently served as Advisor for the Health Commission of the Senate of Italian Republic for the Rare and Neglected Diseases program. Dr Radaelli has been awarded of the highest ranking honour of the Italian Republic by the President and Prime Minister of Italy for "merit acquired in the fields of Science and BioPharma Industry.